Refoxy Pharmaceuticals

Refoxy Pharmaceuticals is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases. Its F.act finder platform identifies molecules modulating FOXO3 for therapeutic effects, initially focusing on fibrotic disorders like idiopathic pulmonary fibrosis (IPF). The company aims to leverage FOXO3's ability to combat cellular stress for novel therapeutics.

Buy Funded Startups lists

Funding Round: Seed+

Funding Amount: €9.1M

Date: 04-Dec-2024

Investors: Boehringer Ingelheim Venture Fund (BIVF), Apollo Health Ventures, NRW Venture, High-Tech Gründerfonds (HTGF)

Markets: Biotech, Pharmaceuticals

HQ: Cologne, Germany, Europe

Founded: 2020

Website: https://www.refoxy.com/

LinkedIn: https://www.linkedin.com/company/refoxy-pharma/

Twitter:

Instagram: